tiprankstipranks
Trending News
More News >
Advertisement

CH:GERD ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
15Bullish
1Neutral
6Bearish
Oscillators
Sell
3Bullish
1Neutral
6Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD is a Sell.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 20-Day exponential moving average is 12.08, making it a Buy.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 50-Day exponential moving average is 11.93, making it a Buy.

L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD (GERD) Pivot Points

Jan 11, 2026, 03:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.23
12.25
12.27
12.29
12.30
12.32
12.33
Fibonacci
12.25
12.27
12.27
12.29
12.30
12.31
12.32

L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD (GERD) Moving Averages

Jan 11, 2026, 03:49 AM
Period
Simple
Exponential
MA5
12.30Buy
12.29Buy
MA10
12.15Buy
12.19Buy
MA20
12.05Buy
12.08Buy
MA50
11.91Buy
11.93Buy
MA100
11.76Buy
11.76Buy
MA200
11.31Buy
11.48Buy
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 10-Day exponential moving average is 12.19, making it a Buy.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 100-Day exponential moving average is 11.76, making it a Buy.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 50-day simple moving average is 11.91, creating a Buy signal.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 100-day simple moving average is 11.76, creating a Buy signal.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) 200-day simple moving average is 11.31, creating a Buy signal.

L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD (GERD) Technical Analysis

Jan 11, 2026, 03:49 AM
Name
Value
Action
RSI (14)
73.20
Sell
STOCH (9,6)
89.71
Sell
STOCHRSI (14)
90.60
Sell
MACD (12,26)
0.12
Sell
ADX (14)
15.82
Buy
Williams %R
-0.68
Sell
CCI (14)
194.50
Sell
ATR (14)
0.10
-
Ultimate Oscillator
64.31
Neutral
ROC
4.19
Buy
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) Relative Strength Index (RSI) is 73.20, creating a Sell signal.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) Trend Strength Indicator (ADX) is 15.82, creating a Buy signal.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) Commodity Channel Index (CCI) is 194.50, creating a Sell signal.
L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD’s (GERD) Price Rate of Change (ROC) is 4.19, creating a Buy signal.

FAQ

Is GERD a Buy, Hold, or Sell?
Based on GERD’s technical indicators, GERD is a Buy.
    What is GERD’s RSI (14)?
    GERD’s RSI (14) is 73.20, which suggests GERD is a Sell.
      What is GERD’s MACD?
      GERD’s MACD is 0.12, which suggests GERD is a Sell.
        What is GERD’s 5-day moving average?
        GERD’s 5-day moving average is 12.30, which suggests GERD is a Buy.
          What is GERD’s 20-day moving average?
          GERD 20-day moving average is 12.05, which suggests GERD is a Buy.
            What is GERD’s 50-day moving average?
            GERD’s 50-day moving average is 11.91, which suggests GERD is a Buy.
              What is GERD’s 200-day moving average?
              GERD’s 200-day moving average is 11.31, which suggests GERD is a Buy.
                What is GERD’s Williams % R (14)?
                GERD’s Williams % R (14) is -0.68, which suggests GERD is a Sell.
                  What is GERD’s CCI (14)?
                  GERD’s CCI (14) is 194.50, which suggests GERD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement